Abstract
Extracranial metastases and their frequency by sites have been described as prognostic factors for survival of patients with brain metastasis. However, these factors must be identified and described in more detail for a large series of patients. Using routine data from the largest German health insurance fund, 5,074 patients with brain metastasis who were diagnosed and treated in 2008 were analyzed to identify the frequency and distribution of extracranial metastatic sites concurrent with brain metastasis in relation to age, gender, and tumor type. Brain metastases were observed in males more frequently than in females (56.4 and 43.6% respectively P < 0.001), and were most often from lung (51.2%), breast (12.3%), and unknown (7.5%) primaries. Extracranial metastatic sites were observed in 58.8% of patients; the number of sites was from 1 to 7, with a mean of 1.11. For the 16 most common primary sites the range was from 0.13 to 1.91 . In 11 of these 16 sites, lungs were the most common concurrent metastatic site. Lung cancer, breast cancer, non-Hodgkin’s lymphoma, and testicular cancer most commonly metastasized to bone, and bladder cancer to kidneys. Different primary tumors have different frequencies and patterns of extracranial metastatic sites concurrently with brain metastasis. The lung is the most common metastatic site of most primary tumors, bone for a few tumors, and kidneys for bladder cancer. For the unknown primary tumor type, screening for these most common metastatic sites must be intensified, in particular when molecular assessment is not available.
Similar content being viewed by others
References
Morris SL, Low SH, A’Hern RP, Eisen TG, Gore ME, Nutting CM, Harrington KJ (2004) A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma. Br J Cancer 91:829–833
Delattre JY, Krol G, Thaler HT, Posner JB (1988) Distribution of brain metastases. Arch Neurol 45:741–744
Aronson SM, Garcia JH, Aronson BE (1964) Metastatic neoplasms of the brain: their frequency in relation to age. Cancer 17:558–563
Walker AE, Robins M, Weinfeld FD (1985) Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 35:219–226
Johnson JD, Young B (1996) Demographics of brain metastasis. Neurosurg Clin N Am 7:337–344
Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK (1978) Malignant melanoma and central nervous system metastases: Incidence, diagnosis, treatment and survival. Cancer 42:660–668
Chason JL, Walker FB, Landers JW (1963) Metastatic carcinoma in the central nervous system and dorsal root ganglia. A prospective autopsy study. Cancer 16:781–787
O’Neill BP, Iturria NJ, Link MJ, Pollock BE, Ballman KV, O’Fallon JR (2003) A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 55:1169–1176
Ranasinghe MG, Sheehan JM (2007) Surgical management of brain metastases. Neurosurg Focus 22(3):E2
Jeremic B, Becker G, Plasswilm L, Bamberg M (2000) Activity of extra-cranial metastases as a prognostic factor influencing survival after radiosurgery of brain metastases. J Cancer Res Clin Oncol 126:475–480
Kondziolka D, Martin JJ, Flickinger JC, Friedland DM, Brufsky AM, Baar J, Agarwala S, Kirkwood JM, Lunsford LD (2005) Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer 104:2784–2791
Rades D, Bohlen G, Pluemer A, Veninga T, Hanssens P, Dunst J, Schild SE (2007) Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer 109:2515–2521
Itoh Y, Fuwa N, Morita K (2003) Radiation therapy for metastatic brain tumors from lung cancer—a review to devise individualized treatment plans. Nagoya J Med Sci 66:119–128
Arteaga CLA, Hanauske AR, Clark GM, Osborne CK, Hazarika I, Pardue RL, Tio F, Hoff DDV (1988) Immunoreactive transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis. Cancer Res 48:5023–5028
Cho KS, Choi YD, Kim SJ et al (2008) A comprehensive prognostic stratification for patients with metastatic renal clear cell carcinoma. Yonsei Med J 49:451–458
Paralkar VR, Li T, Langer CJ (2008) Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a fox chase cancer center retrospective. Clin Lung Cancer 9:116–121
Pilgrim HI (1969) The kinetics of the organ-specific metastasis of a transplantable reticuloendothelial tumor. Cancer Res 29:1200–1205
Guy DS, Samuel WF (2008) Metastatic patterns of cancers. Arch Pathol Lab Med 132:931–939
Isaiah JF (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453–458
Bartelt S, Lutterbach J (2003) Brain metastases in patients with cancer of unknown primary. J Neurooncol 64:249–253
Khansur T, Routh A, Hickman B (1997) Brain metastases from unknown primary site. J Miss State Med Assoc 38:238–242
Salvati M, Cervoni L, Raco A (1995) Single brain metastases from unknown primary malignancies in CT-era. J Neurooncol 23:75–80
AOK (2010) http://www.aok-business.de/wir-ueber-uns/wir-ueber-uns.php?id=0>=aok07&si=AOK71256224008463556. Accessed 1 Dec 2010
WHO (2001) International classification of diseases for oncology, (ICD-O-3), 3rd edn. World Health Organization, Geneva
DIMDI (2007) Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme 10. Revision version 2007. German modification. Vierstellige ausführliche Systematik. http://www.dimdi.de/static/de/klassi/diagnosen/icd10/. Accessed 1 December 2010
Robert Koch Institute (ed) and Association of Population-based Cancer Registries in Germany (ed) (2008) Cancer in Germany 2003–2004. Incidence and trends, 6th edn. Berlin
Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. A randomized controlled trial. JAMA 295:2483–2491
Berge T, Toremalm NG (1975) Bronchial cancer-a clinical and pathological study. I. Histopathology and metastases. Scand J Respir Dis 56:109–119
Santarelli JG, Sarkissian V, Hou LC, Veeravagu A, Tse V (2007) Molecular events of brain metastasis. Neurosurg Focus 22(3):E1
Wronski M, Arbit E (1999) Resection of brain metastases from colorectal carcinoma in 73 patients. Cancer 85:1677–1685
Engenhart R, Kimmig BN, Höver KH, Wowra B, Romahn J, Lorenz WJ, van Kaick G, Wannenmacher M (1993) Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 71:1353–1361
Joseph J, Adler JR, Cox RS, Hancock SL (1996) Linear accelerator-based stereotaxic radiosurgery for brain metastases: the influence of number of lesions on survival. J Clin Oncol 14:1085–1092
Breneman JC, Warnick RE, Albright RE Jr, Kukiatinant N, Shaw J, Armin D, Tew J Jr (1997) Stereotactic radiosurgery for the treatment of brain metastases: results of a single institution series. Cancer 79:551–557
Mori Y, Kondziolka D, Flickinger JC, Kirkwood JM, Agarwala S, Lunsford LD (1998) Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 42:581–589
Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, Abbruzzese JL (2006) Metastatic patterns in adenocarcinoma. Cancer 106:1624–1633
Kebudi R, Ayan I, Görgün O, Ağaoğlu FY, Vural S, Darendeliler E (2005) Brain metastasis in pediatric extra-cranial solid tumors: survey and literature review. J Neurooncol 71:43–48
Aylin P, Bottle A, Majeed A (2007) Use of administrative data or clinical databases as predictors of risk of death in hospital: comparison of models. BMJ 334:1044–1047
Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH (2004) Accuracy of medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J 148:99–104
Luthi JC, Troillet N, Eisenring MC, Sax H, Burnand B, Quan H, Ghali W (2007) Administrative data outperformed single-day chart review for comorbidity measure. Int J Qual Health Care 19:225–231
Quan H, Parsons GA, Ghali WA (2002) Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care 40:675–685
McKee M, Britton A, Black N, McPherson K, Sanderson C, Bain C (1999) Methods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies. BMJ (Clinical Research ed) 319:312–315
Eichler AF, Lamont EB (2009) Utility of administrative claims data for the study of brain metastases: a validation study. J Neurooncol 95:427–431
Busse R, Schreyögg J, Smith PC (2006) Hospital case payment systems in Europe. Health Care Manag Sci 9(3):211–213
Thieme M (2008) Krankenkassen mit ungebrochener Prüfungslust. KU Gesundheitsmanagement 78:48–52
Acknowledgments
The authors would like to acknowledge the scholarship provided by the Ministry of Education and Training of Vietnam (MOET) and the German Academic Exchange Service (DAAD); WIdO of Germany for kindly providing the dataset; and our colleagues in MiG-TU Berlin for help with data collection.
Conflict of Interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vuong, D.A., Rades, D., Vo, S.Q. et al. Extracranial metastatic patterns on occurrence of brain metastases. J Neurooncol 105, 83–90 (2011). https://doi.org/10.1007/s11060-011-0563-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-011-0563-z